Micoy Therapeutics
Micoy Therapeutics, with a valuation of $9.99 million, is raising funds on StartEngine. It is a preclinical-stage biotechnology company focused on developing therapeutics targeting harmful autoantibodies. Micoy Therapeutics’ novel therapies aim to induce immunodeficiency by inhibiting type I interferons and offer a promising approach to protecting against life-threatening viral infections. Prem Premsrirut founded Micoy Therapeutics in June 2024. The current crowdfunding campaign has a minimum target of $123,999.75 and a maximum target of $1.23 million. The campaign proceeds will be used for outside research and development, company employment, regulatory consulting, and diagnostic test development.
Investment Overview
Raised: $96,033
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 10/29/2024
- Close Date
- 01/27/2025
$124,000
$1,234,994
$494
Equity - Common
Pre-Seed
RegCF
$1.75
$9,992,500
Company & Team
Company
- Year Founded
- 2024
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B2C
- Margin
- High
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $0
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 01/27/2025 | StartEngine | $9,992,500 | $96,033 | Equity - Common | Active | RegCF |